Nisa Investment Advisors’s Cytek Biosciences CTKB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.5K | Buy |
4,553
+2,993
| +192% | +$10.2K | ﹤0.01% | 2065 |
|
|
2025
Q1 | $6.26K | Sell |
1,560
-639
| -29% | -$2.56K | ﹤0.01% | 2199 |
|
|
2024
Q4 | $14.3K | Buy |
2,199
+183
| +9% | +$1.19K | ﹤0.01% | 2043 |
|
|
2024
Q3 | $11.2K | Buy |
2,016
+267
| +15% | +$1.48K | ﹤0.01% | 2079 |
|
|
2024
Q2 | $9.76K | Buy |
1,749
+334
| +24% | +$1.86K | ﹤0.01% | 2161 |
|
|
2024
Q1 | $9.5K | Buy |
1,415
+60
| +4% | +$403 | ﹤0.01% | 2047 |
|
|
2023
Q4 | $12.4K | Sell |
1,355
-6,505
| -83% | -$59.3K | ﹤0.01% | 1993 |
|
|
2023
Q3 | $43.4K | Buy |
7,860
+6,600
| +524% | +$36.4K | ﹤0.01% | 1766 |
|
|
2023
Q2 | $10.8K | Sell |
1,260
-830
| -40% | -$7.09K | ﹤0.01% | 2244 |
|
|
2023
Q1 | $19K | Buy |
2,090
+50
| +2% | +$455 | ﹤0.01% | 2022 |
|
|
2022
Q4 | $21K | Sell |
2,040
-41
| -2% | -$422 | ﹤0.01% | 2043 |
|
|
2022
Q3 | $32K | Buy |
2,081
+381
| +22% | +$5.86K | ﹤0.01% | 1903 |
|
|
2022
Q2 | $18K | Buy |
+1,700
| New | +$18K | ﹤0.01% | 2069 |
|